ATL 1102

Names

[ CAS No. ]:
350263-41-1

[ Name ]:
ATL 1102

Biological Activity

[Description]:

ATL 1102 is a novel second-generation antisense oligonucleotide to CD49d mRNA

[Related Catalog]:

Research Areas >> Others

Signaling Pathways >> Cytoskeleton >> Integrin

[References]

[1]. Duchartre Y, Bachl S, Kim HN, et al. Effects of CD49d-targeted antisense-oligonucleotide on α4 integrin expression and function of acute lymphoblastic leukemia cells: Results of in vitro and in vivo studies. PLoS One. 2017;12(11):e0187684.

[2]. Limmroth V, Barkhof F, Desem N, Diamond MP, Tachas G; ATL1102 Study Group. CD49d antisense drug ATL1102 reduces disease activity in patients with relapsing-remitting MS [published correction appears in Neurology. 2015 Jan 6;84(1):105]. Neurology. 2014;83(20):1780-1788.

Chemical & Physical Properties

No Any Chemical & Physical Properties

Related Compounds

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.